Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Translational and Clinical Pharmacology is Scopus-indexed (Q3, CiteScore 3), WoS ESCI. Published by Korean Society Clinical Pharmacology and Therapeutics.
Checked against the index lists dated .
ISSN 2289-0882Verify ISSN ↗2383-5427Verify ISSN ↗
Publisher: Korean Society Clinical Pharmacology and Therapeutics
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 161 / 278 | 42nd | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q3, CiteScore 3.
Translational and Clinical Pharmacology is Q3 in Pharmacology (medical) (rank 161 of 278), by CiteScore 2025.
Translational and Clinical Pharmacology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3, which places it in quartile Q3 at the 42nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.521, quartile Q3, with an H-index of 18.
Translational and Clinical Pharmacology is published by Korean Society Clinical Pharmacology and Therapeutics. Its print ISSN is 2289-0882 and its online ISSN is 2383-5427.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Translational and Clinical Pharmacology has an h-index of 24 and a 2-year mean of 2.41 citations per paper (OpenAlex). Its Scopus CiteScore is 3, quartile Q3. On 2-year citations it ranks #105 of 271 Scopus journals in Pharmacology (medical).
Translational and Clinical Pharmacology published 21 papers in 2025; its busiest recent year was 2017 with 36. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2021–2026), authors are most often from South Korea (86.3%), Japan (2.6%) and China (2.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (5.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.